Parameterizing Risk-Benefit Models from Primary Care Data: Recurrence and Exacerbation

Aug-10

AUTHORS : Andy Maguire OR Betina Blak (Details for study: CSD EPIC) now works at AstraZeneca, Horizon Place, 600 Capability Green, Luton, Bedfordshire LU1 3LU, UK – Email: betina.blak@astrazeneca.com

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 19(S1):269-270

DOI : 10.1002/pds.2019

Parameterizing Risk-Benefit Models from Primary Care Data: Recurrence and Exacerbation

More publications

Characteristics and Outcomes of Over a Million Patients with Infammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data Resource

Defining Mental Health Conditions Within Primary Care Data: A Validation Study With a Mixed Qualitative and Quantitative Approach

Trends in clinical workload in UK primary care 2005–2019: a retrospective cohort study